Search results
Earnings call: Virios Therapeutics reports on Q1 2024 progress By Investing.com
Investing.com· 3 days agoVirios Therapeutics (NASDAQ: VIRI) discussed their first quarter financial results and provided an ...
2 COVID variants called ‘FLiRT’ are making the rounds: Here are the symptoms
The Patriot-News· 6 days agoA new set of COVID-19 variants are spreading in the U.S. after being detected in wastewater...
GEE Group to Hold Investor Conference Call to Discuss 2024 Fiscal Second Quarter and YTD Results
The Sacramento Bee· 1 hour ago(NYSE American:JOB) ("the Company" or "GEE Group"), a provider of professional staffing services and human resource solutions, today announced that it will hold an investor ...
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
NewMediaWire via Yahoo Finance· 16 hours agoPresented data on GEO-CM04S1 at World Vaccine Congress, delineating the unique immune system driven...
Is AMC Stock A Buy Now After Roaring Kitty Returns? Meme Stock Soars 308% In May So Far, Retakes Key...
Investor's Business Daily· 15 hours agoIn morning trading on Monday, AMC stock jumped 41% and hit as high as 4.17. At Tuesday's...
Meta to shut down its Workplace business communications platform - SiliconANGLE
SiliconANGLE· 13 hours agoMeta Platforms Inc. today announced plans to shut down Workplace, an enterprise version of Facebook that competes with Slack, in early 2026. The company notified customers ...
Fed Rate Cuts Remain Elusive. Why Markets Can’t Count on Inflation Data for Insight and 5 Other...
Barrons.com· 2 days agoThere will be plenty of updates on their thinking, though, with almost a dozen speaking events this...
How Is Disney Doing?
Motley Fool via Yahoo Finance· 1 day agoBut again, I guess we're going to have to wait and see because they're going to have to invest a lot of money in the streaming endeavor for some time to...
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 2 days agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel COVID...
Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update -...
Benzinga· 6 days ago- Top-line results from the ongoing investigator-initiated Bateman Horne Center Long-COVID phase 2 featuring valacyclovir and celecoxib (IMC-2) expected in the second-half ...